Highlights in lymphoma: overview of the 11th International Conference on Malignant Lymphoma

Annalisa Chiappella1, Umberto Vitolo

  • 1Hematology II, San Giovanni Battista Hospital and University, Torino, Italy.

Expert Review of Hematology
|September 24, 2011
PubMed

The 11th International Conference on Malignant Lymphoma (ICML), the main international forum devoted to basic and clinical research in lymphoid neoplasms, took place in Lugano, Switzerland, from 15 to 18 June 2011. In 2011, 3200 experts in lymphoma from 76 countries attended the meeting. ICML represents the most important forum for the discussion of all aspects relating to basic research, clinical data and results of trials in the treatment of malignant lymphoma worldwide. The incidence of Hodgkin's and non-Hodgkin's lymphoma is increasing. Treatment of lymphoma is heterogeneous, with effective results seen with standard chemotherapy, immunotherapy, high-dose chemotherapy with transplantation and radiotherapy. The biological basis of the growth of lymphoma explains the rationale for the introduction of experimental new drugs in monotherapy or in combination with consolidate schemes. The results have been promising and these issues were discussed during the meeting. On this basis, the ICML report was focused on the most topical, interesting or thought-provoking issues in the treatment of lymphoma.

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Lymphatic Vessels and Lymph Transport01:16

Lymphatic Vessels and Lymph Transport

Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular spaces.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...